FAM227A
gene geneOn this page
Summary
FAM227A (family with sequence similarity 227 member A, HGNC:44197) is a protein-coding gene on chromosome 22q13.1, encoding Protein FAM227A (F5H4B4).
At a glance
- GWAS associations: 9
- Clinical variants (ClinVar): 93 total
- MANE Select transcript:
NM_001013647
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:44197 |
| Approved symbol | FAM227A |
| Name | family with sequence similarity 227 member A |
| Location | 22q13.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000184949 |
| Ensembl biotype | protein_coding |
| Entrez | 646851 |
Gene structure
Transcript identifiers
Ensembl transcripts: 11 — 6 protein_coding_CDS_not_defined, 3 protein_coding, 2 retained_intron
ENST00000355830, ENST00000424706, ENST00000484582, ENST00000490082, ENST00000535113, ENST00000540952, ENST00000541689, ENST00000543295, ENST00000543828, ENST00000544346, ENST00000608409
RefSeq mRNA: 4 — MANE Select: NM_001013647
NM_001013647, NM_001291030, NM_001384270, NM_001384271
CCDS: CCDS93164
Canonical transcript exons
ENST00000535113 — 17 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002259648 | 38578118 | 38586199 |
| ENSE00002261298 | 38591435 | 38591540 |
| ENSE00003479253 | 38639655 | 38639724 |
| ENSE00003500476 | 38636451 | 38636597 |
| ENSE00003502278 | 38623172 | 38623279 |
| ENSE00003513808 | 38650027 | 38650262 |
| ENSE00003531423 | 38620212 | 38620291 |
| ENSE00003554745 | 38605254 | 38605348 |
| ENSE00003571280 | 38626180 | 38626303 |
| ENSE00003572340 | 38597204 | 38597356 |
| ENSE00003604883 | 38628834 | 38628935 |
| ENSE00003607556 | 38628238 | 38628342 |
| ENSE00003642881 | 38638746 | 38638822 |
| ENSE00003646404 | 38599764 | 38599921 |
| ENSE00003663355 | 38607389 | 38607476 |
| ENSE00003691402 | 38645563 | 38645645 |
| ENSE00003921502 | 38656120 | 38656392 |
Expression profiles
Bgee: expression breadth ubiquitous, 129 present calls, max score 87.86.
FANTOM5 (CAGE): breadth broad, TPM avg 1.6136 / max 59.9357, expressed in 731 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 194201 | 0.6492 | 360 |
| 194199 | 0.5384 | 191 |
| 194200 | 0.4038 | 194 |
| 194198 | 0.0221 | 5 |
Top tissues by expression
132 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right uterine tube | UBERON:0001302 | 87.86 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 79.59 | gold quality |
| right testis | UBERON:0004534 | 79.12 | gold quality |
| left testis | UBERON:0004533 | 78.95 | gold quality |
| testis | UBERON:0000473 | 78.81 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 76.00 | gold quality |
| ventricular zone | UBERON:0003053 | 74.37 | gold quality |
| pituitary gland | UBERON:0000007 | 73.38 | gold quality |
| stromal cell of endometrium | CL:0002255 | 73.15 | gold quality |
| adenohypophysis | UBERON:0002196 | 72.49 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 72.03 | gold quality |
| cortical plate | UBERON:0005343 | 71.69 | gold quality |
| sural nerve | UBERON:0015488 | 71.16 | gold quality |
| fallopian tube | UBERON:0003889 | 70.75 | gold quality |
| endometrium | UBERON:0001295 | 70.37 | gold quality |
| ganglionic eminence | UBERON:0004023 | 70.15 | gold quality |
| corpus callosum | UBERON:0002336 | 68.25 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 65.80 | gold quality |
| thyroid gland | UBERON:0002046 | 65.17 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 64.88 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 64.76 | gold quality |
| colonic epithelium | UBERON:0000397 | 64.57 | silver quality |
| caudate nucleus | UBERON:0001873 | 64.02 | gold quality |
| cortex of kidney | UBERON:0001225 | 63.66 | gold quality |
| hypothalamus | UBERON:0001898 | 63.58 | gold quality |
| metanephros cortex | UBERON:0010533 | 63.13 | gold quality |
| nucleus accumbens | UBERON:0001882 | 62.95 | gold quality |
| left uterine tube | UBERON:0001303 | 62.45 | gold quality |
| kidney | UBERON:0002113 | 62.43 | gold quality |
| endocervix | UBERON:0000458 | 62.26 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 10.42 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
249 targeting FAM227A, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-429 | 100.00 | 73.44 | 2698 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-200B-3P | 100.00 | 73.31 | 2693 |
| HSA-MIR-200C-3P | 100.00 | 73.35 | 2685 |
| HSA-MIR-4713-3P | 100.00 | 65.92 | 505 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-4673 | 100.00 | 66.64 | 1490 |
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-126-5P | 100.00 | 72.71 | 3180 |
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-7110-3P | 100.00 | 73.18 | 2486 |
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-4682 | 100.00 | 68.89 | 1258 |
| HSA-MIR-6873-3P | 100.00 | 71.42 | 2626 |
| HSA-MIR-4789-3P | 99.99 | 70.75 | 2484 |
| HSA-MIR-150-5P | 99.99 | 66.69 | 1976 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-4531 | 99.99 | 69.70 | 3181 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-4482-3P | 99.98 | 72.50 | 3147 |
| HSA-MIR-4645-5P | 99.98 | 65.81 | 1284 |
| HSA-MIR-4789-5P | 99.98 | 70.76 | 2721 |
| HSA-MIR-6888-3P | 99.97 | 65.95 | 1170 |
| HSA-MIR-512-3P | 99.97 | 67.35 | 1049 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-4666A-3P | 99.96 | 71.71 | 3434 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Fam227a | ENSMUSG00000042564 |
| rattus_norvegicus | Fam227a | ENSRNOG00000021795 |
Protein
Protein identifiers
Protein FAM227A — F5H4B4 (reviewed: F5H4B4)
All UniProt accessions (3): F5H4B4, A0A0A0MRD0, A0A2R8YCE3
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the FAM227 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| F5H4B4-1 | 1 | yes |
| F5H4B4-2 | 2 |
RefSeq proteins (4): NP_001013669, NP_001277959, NP_001371199, NP_001371200 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR029417 | FAM227 | Family |
Pfam: PF14922
UniProt features (15 total): compositionally biased region 4, region of interest 3, modified residue 3, splice variant 2, sequence conflict 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-F5H4B4-F1 | 65.23 | 0.14 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (3): 349, 343, 348
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 64 (showing top):
chr22q13, ZWANG_DOWN_BY_2ND_EGF_PULSE, ASH1L_TARGET_GENES, BANP_TARGET_GENES, E2F2_TARGET_GENES, FOXJ2_TARGET_GENES, HHEX_TARGET_GENES, MAFG_TARGET_GENES, NKX2_2_TARGET_GENES, SKIL_TARGET_GENES, TEAD2_TARGET_GENES, CASP8AP2_TARGET_GENES, ZIM3_TARGET_GENES, MIR1297, MIR4666A_3P
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
204 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| FAM227A | PRSS38 | A1L453 | 527 |
| FAM227A | SLC35E4 | Q6ICL7 | 507 |
| FAM227A | ITPRIPL2 | Q3MIP1 | 447 |
| FAM227A | HSBP1L1 | C9JCN9 | 438 |
| FAM227A | CFAP70 | Q5T0N1 | 394 |
| FAM227A | SUSD5 | O60279 | 378 |
| FAM227A | TAFA2 | Q8N3H0 | 371 |
| FAM227A | COQ10B | Q9H8M1 | 357 |
| FAM227A | EEIG1 | Q5T9C2 | 354 |
| FAM227A | SUN2 | Q9UH99 | 348 |
| FAM227A | CFAP251 | Q8TBY9 | 338 |
| FAM227A | TMSB15A | P0CG34 | 317 |
| FAM227A | TAFA5 | Q7Z5A7 | 316 |
| FAM227A | PRTG | Q2VWP7 | 312 |
| FAM227A | DIP2C | Q9Y2E4 | 311 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| FAM227A | ARPC1B | psi-mi:“MI:0915”(physical association) | 0.400 |
BioGRID (2): ARPC1B (Proximity Label-MS), FAM227A (Cross-Linking-MS (XL-MS))
ESM2 similar proteins: A0A0R4I9Y1, A0A0R4IBK5, A2ARZ3, A5WUT8, A6NKT7, A7S7F2, E9Q3L2, E9Q555, F1QB81, F5H4B4, H2QII6, O08662, O14715, O15050, O43310, P0DJD0, P0DJD1, P13864, P42356, P49792, Q06190, Q0V9S3, Q0VF22, Q16533, Q1LVQ2, Q24K09, Q2T9I9, Q4R6W9, Q4V847, Q5U228, Q63HN8, Q65Z40, Q6NU22, Q6NU51, Q7TPV2, Q7Z3J3, Q80TA9, Q811D2, Q86Y13, Q921I6
Diamond homologs: F5H4B4, Q4R7D5, Q6AXP3, Q9D518, Q96M60
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
93 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 77 |
| Likely benign | 7 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
3351 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 22:38586100:T:TA | donor_gain | 1.0000 |
| 22:38591414:A:AC | donor_gain | 1.0000 |
| 22:38591432:T:TA | donor_gain | 1.0000 |
| 22:38623170:AC:A | donor_gain | 1.0000 |
| 22:38623171:CC:C | donor_gain | 1.0000 |
| 22:38636445:CCTCA:C | donor_loss | 1.0000 |
| 22:38636447:TCA:T | donor_loss | 1.0000 |
| 22:38636448:CACCT:C | donor_loss | 1.0000 |
| 22:38636449:A:T | donor_loss | 1.0000 |
| 22:38636450:C:CA | donor_loss | 1.0000 |
| 22:38636594:TTTT:T | acceptor_gain | 1.0000 |
| 22:38636595:TTT:T | acceptor_gain | 1.0000 |
| 22:38636596:TT:T | acceptor_gain | 1.0000 |
| 22:38636598:C:CC | acceptor_gain | 1.0000 |
| 22:38636604:C:CT | acceptor_gain | 1.0000 |
| 22:38636605:A:T | acceptor_gain | 1.0000 |
| 22:38638744:AC:A | donor_gain | 1.0000 |
| 22:38638745:CC:C | donor_gain | 1.0000 |
| 22:38638818:CTTGA:C | acceptor_gain | 1.0000 |
| 22:38638819:TTGA:T | acceptor_gain | 1.0000 |
| 22:38638823:C:CC | acceptor_gain | 1.0000 |
| 22:38650051:T:TA | donor_gain | 1.0000 |
| 22:38586045:A:AC | donor_gain | 0.9900 |
| 22:38586045:ATTTT:A | donor_gain | 0.9900 |
| 22:38586046:T:C | donor_gain | 0.9900 |
| 22:38591359:A:AC | donor_gain | 0.9900 |
| 22:38591360:C:CC | donor_gain | 0.9900 |
| 22:38591415:A:C | donor_gain | 0.9900 |
| 22:38591439:G:C | donor_gain | 0.9900 |
| 22:38591457:T:TA | donor_gain | 0.9900 |
AlphaMissense
3806 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 22:38626265:G:C | S255R | 0.996 |
| 22:38626265:G:T | S255R | 0.996 |
| 22:38626267:T:G | S255R | 0.996 |
| 22:38599859:G:C | S428R | 0.993 |
| 22:38599859:G:T | S428R | 0.993 |
| 22:38599861:T:G | S428R | 0.993 |
| 22:38626189:A:G | W281R | 0.992 |
| 22:38626189:A:T | W281R | 0.992 |
| 22:38628864:G:C | S197R | 0.992 |
| 22:38628864:G:T | S197R | 0.992 |
| 22:38628866:T:G | S197R | 0.992 |
| 22:38626250:A:C | F260L | 0.989 |
| 22:38626250:A:T | F260L | 0.989 |
| 22:38626252:A:G | F260L | 0.989 |
| 22:38623247:A:G | W295R | 0.988 |
| 22:38623247:A:T | W295R | 0.988 |
| 22:38628857:A:G | W200R | 0.987 |
| 22:38628857:A:T | W200R | 0.987 |
| 22:38628861:A:C | F198L | 0.985 |
| 22:38628861:A:T | F198L | 0.985 |
| 22:38628863:A:G | F198L | 0.985 |
| 22:38626217:C:A | K271N | 0.983 |
| 22:38626217:C:G | K271N | 0.983 |
| 22:38626262:G:C | F256L | 0.983 |
| 22:38626262:G:T | F256L | 0.983 |
| 22:38626264:A:G | F256L | 0.983 |
| 22:38626220:G:C | F270L | 0.982 |
| 22:38626220:G:T | F270L | 0.982 |
| 22:38626222:A:G | F270L | 0.982 |
| 22:38628860:A:G | W199R | 0.982 |
dbSNP variants (sampled 300 via entrez): RS1000014531 (22:38632237 G>A), RS1000087048 (22:38639456 G>A), RS1000090830 (22:38598887 C>T), RS1000117809 (22:38615761 T>A), RS1000147590 (22:38622465 G>A), RS1000193868 (22:38653913 G>A,T), RS1000199509 (22:38650931 C>T), RS1000201548 (22:38643309 C>G), RS1000275379 (22:38615487 A>G), RS1000299587 (22:38598509 A>T), RS1000343023 (22:38621710 C>T), RS1000379090 (22:38616658 C>G), RS1000403443 (22:38647925 C>T), RS1000443881 (22:38627816 C>T), RS1000464455 (22:38588944 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
9 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003818_40 | Resting heart rate | 5.000000e-16 |
| GCST006019_42 | Gamma glutamyl transferase levels | 3.000000e-10 |
| GCST006979_828 | Heel bone mineral density | 6.000000e-34 |
| GCST011349_32 | Gamma glutamyl transferase levels | 6.000000e-11 |
| GCST90002384_505 | Hemoglobin | 2.000000e-11 |
| GCST90002390_329 | Mean corpuscular hemoglobin | 3.000000e-14 |
| GCST90002392_224 | Mean corpuscular volume | 1.000000e-19 |
| GCST90002397_608 | Mean spheric corpuscular volume | 4.000000e-17 |
| GCST90013406_211 | Liver enzyme levels (alkaline phosphatase) | 2.000000e-10 |
EFO canonical traits (5, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004532 | serum gamma-glutamyl transferase measurement |
| EFO:0009270 | heel bone mineral density |
| EFO:0004509 | hemoglobin measurement |
| EFO:0004527 | mean corpuscular hemoglobin |
| EFO:0004533 | alkaline phosphatase measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
9 total (human), top 9 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, increases methylation | 2 |
| trichostatin A | affects expression | 1 |
| sodium arsenite | decreases expression | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Smoke | increases abundance, increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Okadaic Acid | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.